PrivateSurgical/Medical
Singapore
Biobot Surgical
Robotic transperineal prostate biopsy/ablation with MRI-ultrasound fusion imaging for precision targeting.
biobotsurgical.comPrivate
Valuation
Unranked (no confirmed valuation)
Rank on board
$38.7M
Total raised
2007
Founded
Profile
| Sector | Surgical robots |
|---|---|
| Value chain | Integrator |
| Flagship | iSR'obot Mona Lisa |
| Headquarters | |
| Valuation | Private. Source: Urology Times |
Regulatory record
FDA clearances: 7
First 12 Aug 2011, latest 21 Dec 2023. Every 510(k) and De Novo filed under the company's name.
- iSR`obot Mona Lisa 2.021 Dec 2023 · K232320 · Applicant: Biobot Surgical Pte., Ltd.
- iSRobot Mona Lisa 2.022 Dec 2021 · K213411 · Applicant: Biobot Surgical Pte., Ltd.
- iSR'obot Mona Lisa 1.08 Jul 2021 · K203659 · Applicant: Biobot Surgical Pte., Ltd.
- iSR'obot Biopsy Kit16 May 2017 · K163502 · Applicant: Biobot Surgical Pte., Ltd.
- iSR'obot MRI-US Fusion6 Oct 2016 · K161109 · Applicant: Biobot Surgical Pte., Ltd.
- ISR'OBOT MONA LISA7 Jun 2013 · K130944 · Applicant: Biobot Surgical Pte., Ltd.
Show 1 earlier clearances
- ISROBOT MONA LISA12 Aug 2011 · K111347 · Applicant: Biobot Surgical Pte., Ltd.
Source: FDA 510(k) database via openFDA, searched by applicant name, with partners and spun-off businesses removed. PMA approvals are not listed here.
Peers in Surgical/Medical
Company data updated 2026-11-16. All robot companies →